A Phase II Study of Ramucirumab and Somatostatin Analog Therapy in Patients with Advanced Neuroendocrine Tumors.
ONCOLOGIST(2025)
Key words
ramucirumab,extrapancreatic neuroendocrine tumors,carcinoid tumors
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined